Status:
COMPLETED
End-tidal Oxygen Can Reliably Predict the Arterial Partial Pressure of Oxygen Among Emergency Department Patients
Lead Sponsor:
New York City Health and Hospitals Corporation
Conditions:
Intubation Complication
Eligibility:
All Genders
18+ years
Brief Summary
Recent studies have shown that end tidal oxygen (ETO2) monitoring can be useful to determine the adequacy of preoxygenation. No study has assessed the correlation between ETO2 values obtained during p...
Detailed Description
Rapid Sequence Intubation (RSI) is the preferred and most commonly-used method of definitive airway management among critically ill emergency department (ED) patients requiring intubation. Adequate pr...
Eligibility Criteria
Inclusion
- All patients undergoing rapid sequence intubation.
Exclusion
- Patients presenting to the emergency department in cardiac or traumatic arrest
- Patients who received bi-level positive airway pressure (BiPAP) as the primary delivery of preoxygenation.
Key Trial Info
Start Date :
October 15 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 30 2017
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT03842306
Start Date
October 15 2017
End Date
December 30 2017
Last Update
February 18 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYC H+H/Lincoln
The Bronx, New York, United States, 10451